
GLP-1 and obesity medicine news.
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 468 | Founded | a year ago | Last Issue | 5 days ago |
| Active | |||||

If you want to know where obesity is headed in the near term, pay attention to one word: amylin.
We have been following Zealand Pharma’s petrelintide for years, so the drug itself is not the story today. What is changing is the conversatio...
If you have followed On The Pen for any length of time, you have heard us talk about the cardiovascular benefits of GLP-1 drugs again and again. Wegovy has shown a reduction in major cardiovascular events, the broader GLP-1 class continues...
The On The Pen community has spent a lot of time talking about how effective the Wegovy Pill has been at expanding the GLP-1 market, but the lesser asked question for those on the pen is: would you switch?
Especially for those who are payi...
Eli Lilly just put another number on the board that is going to get a lot of attention in obesity medicine: 29% average weight loss at Week 31 with a combination of tirzepatide and the selective amylin receptor agonist eloralintide. In the...
I’m preparing for today’s podcast, keep an eye out for it this evening. But this afternoon I cannot move on until I can get away from this nagging thought. I’m going to lay it out here, in the hopes you’ll share your thoughts on it. So ofte...
Subscribers, engagement, traffic and sponsorship for ON THE PEN.
| Subscribers | Engagement | 81 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Where ON THE PEN ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 182 | Monthly Search Traffic | Top Keywords |
|---|
How this newsletter ranks in the official Substack charts.
| #223 | |
| #158 |
The writers behind this newsletter.
On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. On The Pen is a top Substack best-seller.
You can find recent issues that have been published by ON THE PEN on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to ON THE PEN, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch ON THE PEN as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact ON THE PEN using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like ON THE PEN. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.